The dialogue between medical experts focuses on breast cancer

Ti Gong

Increasing public awareness of breast cancer, as well as the accuracy of early screening and imaging is key to increasing survival rates, doctors said at the third China International Import Expo.

A dialogue between doctors, experts and industry insiders was hosted by the global health giant Roche Diagnostics and GE during the import expo to discuss the diagnosis and treatment of breast cancer, its pathology and the value of the application clinic of advanced diagnostic technologies such as medical imaging.

The aim is to promote early screening, diagnosis and treatment of breast cancer and to increase the precise diagnosis and level of management of the disease.

Breast cancer is the most common malignancy among Chinese women. There are about 304,000 new cases of breast cancer in China every year with a rising figure, which seriously threatens the health of Chinese women.

However, many women are not fully aware of breast cancer, missing out on the best treatment time.

The early detection rate of breast cancer in China is less than 30%.

Early diagnosis and tailored treatment therapy are the key to personalized breast cancer treatment.

Medical imaging checks play an important role in the early and accurate diagnosis and treatment of breast cancer.

“The survival rate of different stages of breast cancer patients varies significantly,” said Xue Yunjing, deputy director of medical imaging department at Fujian Medical University. “Raising public awareness and increasing the accuracy of early screening and imaging is the only way to significantly increase this rate.

“With the development of precise solutions for breast cancer diagnosis and treatment and the assistance of new technologies such as artificial intelligence in medical imaging, early detection and nationwide screening coverage have been lifted and the Clinical application of precise disease imaging has been significantly developed. “

Yang Wentao of the Shanghai Cancer Center’s Pathology Department, added, “Pathological diagnosis is critical to breast cancer diagnosis. Efficient, high-quality test platform and reagent, comprehensive standard operating procedure (SOP), and quality control. are among the most important factors to ensure the efficiency and quality of the tests “.

Richard Yiu, general manager of Roche Diagnostics China, said the company will join with its partners to create a disease management ecosystem based on accurate diagnosis. This will promote personalized diagnosis and treatment development for diseases such as breast cancer, fueling the “healthy China 2030” project and benefiting Chinese patients.